Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong nine-month performance, ...

Euronext (EPA:ENX) reported strong financial results for the full year 2024, showcasing significant revenue and earnings growth. The company's revenue reached €1,626.9 million, marking a 10.3% ...